Discovery Life Sciences is a global market leader in biospecimen analysis, procurement, and distribution for the pharmaceutical, biotechnology, and diagnostics industries. Known as the 'Biospecimen and Biomarker Specialists™', they leverage deep scientific expertise and an extensive global network to provide high-quality human biospecimens and expert multi-omic biomarker services. Their offerings accelerate the discovery, research, and development of new therapies and diagnostic tools, supporting scientists from basic research through to clinical trials. Key service areas include genomics, proteomics, pathology, and cell services, all designed to advance precision medicine.
Serves as the central hub for corporate leadership, strategic operations, research and development, and extensive laboratory services, including advanced genomics and molecular pathology.
Situated within the HudsonAlpha Institute for Biotechnology, a leading genomics and biotech research park, facilitating collaboration and access to cutting-edge technologies.
A dynamic, science-driven environment fostering innovation, collaboration, and precision. Employees are dedicated to advancing medical research and contributing to breakthroughs in life sciences.
The Huntsville headquarters is strategically positioned in a major U.S. biotechnology hub, enabling access to a skilled talent pool, state-of-the-art research facilities, and a collaborative scientific community.
Discovery Life Sciences supports pharmaceutical, biotechnology, and diagnostic development globally through strategically located, state-of-the-art laboratories and operational hubs in North America and Europe. This global footprint enables localized biospecimen procurement, advanced analytical services (genomics, proteomics, pathology, cell services), and efficient logistics, ensuring timely and high-quality support for international research programs and clinical trials.
701 McMillian Way NW
Huntsville
Alabama
USA
Address: 920 Springdale Drive, Exton, PA 19341
Serves as a key East Coast hub for cellular products and services, catering to the dense pharmaceutical and biotech presence in the region.
Address: 100 Technology Drive, Marshall, NC 28753
Offers critical biorepository and logistical support services, complementing Discovery's broader biospecimen and analytical capabilities.
Address: Babraham Research Campus, Cambridge, CB22 3AT, UK
Provides localized access to Discovery's comprehensive biomarker services and biospecimen solutions for the European pharmaceutical and biotechnology market.
Address: Im Neuenheimer Feld 583, 69120 Heidelberg, Germany
Strengthens Discovery's presence in continental Europe, offering specialized analytical capabilities and supporting clinical research in Germany and surrounding countries.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Discovery Life Sciences' leadership includes:
Discovery Life Sciences has been backed by several prominent investors over the years, including:
Discovery Life Sciences has made strategic appointments to strengthen its scientific and commercial leadership, particularly in cell and gene therapy and commercial operations, indicating growth and specialization.
Discover the tools Discovery Life Sciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Discovery Life Sciences commonly uses the email format combining the first initial and last name. Understanding this pattern can be useful for professional communication.
[first_initial][last]@discoverylifesciences.com
Format
jdoe@discoverylifesciences.com
Example
85%
Success rate
Business Wire • December 5, 2023
Discovery Life Sciences announced the expansion of its bioprocessing and GMP-compliant cell manufacturing capabilities at its European headquarters in Cambridge, UK. This expansion enhances their capacity to support cell and gene therapy developers with high-quality starting materials and manufacturing services....more
Business Wire • August 1, 2023
Discovery Life Sciences announced the appointment of Adam G. Gislason as its new Chief Commercial Officer. Gislason brings extensive experience in life sciences commercial strategy and will lead Discovery's global sales, marketing, and customer support efforts....more
PR Newswire • February 21, 2023
Discovery Life Sciences appointed Michael Pisano, Ph.D. as Chief Scientific Officer, Cell and Gene Therapy. This strategic hire aims to bolster Discovery's capabilities and scientific leadership in the rapidly growing field of cell and gene therapies....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Discovery Life Sciences, are just a search away.